Quest Diagnostics Incorporated is a leader in diagnostic testing and services, providing diverse healthcare solutions to clients worldwide. The company shows promising growth potential with robust financial health metrics. However, challenges exist in the highly competitive healthcare sector.
The fundamental rating indicates a strong financial position, with particular strength in return on assets.
| Category | Score | |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return On Equity | 4 | |
| Return On Assets | 5 | |
| Debt To Equity | 1 | |
| Price To Earnings | 3 | |
| Price To Book | 3 |
The historical data shows stability in Quest Diagnostics' financial scoring over time.
| Date | Overall Score | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 5/7/2026 | 4 | 4 | 4 | 5 | 1 | 3 | 3 |
| Previous | 0 | 4 | 4 | 5 | 1 | 3 | 3 |
Analyst expectations reveal a consensus price that suggests stable growth.
| High | Low | Median | Consensus |
|---|---|---|---|
| $235 | $210 | $220 | $220.57 |
Consensus among analysts suggests a 'Hold' recommendation.
| Rating | Number | |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 13 | |
| Hold | 18 | |
| Sell | 3 | |
| Strong Sell | 0 |
Quest Diagnostics maintains a solid financial standing, supporting their strong performance in the diagnostic and healthcare sector. The company's innovative solutions and expansive market presence offer significant opportunities for growth. However, the competitive dynamics of the healthcare industry and regulatory risks pose potential challenges. With a current 'Hold' rating from analysts, stakeholders may consider monitoring market trends and company reports before making substantial investment decisions.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.